Company Filing History:
Years Active: 2011-2014
Title: Innovations by Inventor Guillaume Benoist
Introduction
Guillaume Benoist is a notable inventor based in Chartres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 2 patents, Benoist's work focuses on enhancing the efficacy and safety of medication administration.
Latest Patents
Benoist's latest patents include a sublingual coated tablet of fentanyl. This invention relates to a fentanyl-coated tablet and the method for its preparation. The second patent involves low-dose tablets that are obtained by directly compressing microgranules. These microgranules consist of a neutral support covered by a polymeric layer containing at least one pharmaceutically acceptable polymer. This design allows for the modified release of active substances in an aqueous medium. The inventive tablets exhibit a matrix effect similar to that of conventional matrix tablets, which depends on the nature of the polymer(s) used. This matrix effect enables the modification of the release profile of the transported active substance based on the type of polymer used. These tablets are particularly suited for administering active substances in low to very low doses.
Career Highlights
Guillaume Benoist is currently associated with Ethypharm, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulation technologies.
Collaborations
Benoist has collaborated with notable colleagues such as Pascal Oury and Catherine Herry, contributing to a dynamic research environment that fosters innovation.
Conclusion
Guillaume Benoist's contributions to pharmaceutical innovations, particularly in drug delivery systems, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving patient care through advanced medication technologies.